EX-FILING FEES 6 d259474dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Eli Lilly and Company

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
    

Security

Type

 

Security

Class

Title

 

Fee

Calculation

or Carry

Forward

Rule

 

Amount

Registered

 

Proposed

Maximum

Offering

Price Per

Unit

 

Maximum

Aggregate

Offering

Price

 

Fee

Rate

 

Amount of

Registration

Fee

 

Carry

Forward

Form

Type

 

Carry

Forward

File

Number

 

Carry

Forward

Initial

Effective

Date

 

Filing Fee

Previously

Paid In

Connection

with Unsold

Securities to

be Carried

Forward

 

Newly Registered Securities

                         

Fees to Be

Paid

  Equity   Common Stock(1)  

Rule 456(b) and

Rule 457(r) (2)

 

(3)(4)

  (3)(4)   (3)(4)(5)   (2)   (2)                
  Equity   Preferred Stock(1)  

Rule 456(b) and

Rule 457(r) (2)

 

(3)(4)

  (3)(4)   (3)(4)(5)   (2)   (2)                
  Equity   Depositary Shares representing Preferred Stock(1)  

Rule 456(b) and

Rule 457(r) (2)

 

(3)(4)

  (3)(4)   (3)(4)(5)   (2)   (2)                
  Debt   Debt Securities(1)  

Rule 456(b) and

Rule 457(r) (2)

 

(3)(4)

  (3)(4)   (3)(4)(5)   (2)   (2)                
  Other   Warrants(1)  

Rule 456(b) and

Rule 457(r) (2)

 

(3)(4)

  (3)(4)   (3)(4)(5)   (2)   (2)                
  Other   Stock Purchase Contracts(1)  

Rule 456(b) and

Rule 457(r) (2)

 

(3)(4)

  (3)(4)   (3)(4)(5)   (2)   (2)                
  Other   Stock Purchase Units(1)  

Rule 456(b) and

Rule 457(r) (2)

 

(3)(4)

  (3)(4)   (3)(4)(5)   (2)   (2)                
                         

Fees

Previously

Paid

  N/A   N/A   N/A   N/A   N/A   N/A       N/A                
 
Carry Forward Securities
                         

Carry

Forward

Securities

  N/A   N/A   N/A   N/A       N/A           N/A   N/A   N/A   N/A
                   
    Total Offering Amounts        N/A       N/A                
                   
    Total Fees Previously Paid                N/A                
                   
    Total Fee Offsets                N/A                
                   
    Net Fee Due                N/A                

 

  (1)

Separate consideration may or may not be received for securities that are issuable on exercise, conversion, settlement or exchange of other securities.

  (2)

In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, Eli Lilly and Company (the “Registrant”) is deferring payment of all of the registration fee. Registration fees will be paid subsequently on a “pay as you go” basis. The Registrant will calculate the registration fee applicable to an offer of securities pursuant to this Registration Statement based on the fee payment rate in effect on the date of such fee payment.

  (3)

An indeterminate aggregate initial offering price and number or amount of the securities of each identified class is being registered as may from time to time be issued at indeterminate prices, including securities that may be issued upon exercise, conversion, settlement or exchange of, any securities offered hereunder.

  (4)

Not specified as to each class of securities to be registered, pursuant to General Instruction II.E. of Form S-3.

  (5)

Exclusive of accrued interest and accumulated dividends, if any.